,

–

Ayub, A., Mackness, M.I., Arrol, S., Mackness, B., Patel, J., Durrington, P.N.,

Serum paraoxonase after myocardial infarction. Arter- ioscler. Thromb. Vasc. Biol.

,

–

Sanghera, D.K., Aston, C.E., Saha, N., Kamboh, M.I.,

DNA polymorphisms in two paraoxonase genes (PON

and PON

) are associated with the risk of coronary heart disease. Am. J. Hum. Genet.

(

),

–

Ruitz, J., Blanche´, H., James, R.W., Garin, C.B., Vaisse, C., Charpentier, G., Cohen, N., Morabia, A., Passa, P., Froguel, P.,

Gln-Arg

taken into consideration (Lander and Schork, 1994). To avoid an admixture of genetically non-homogeneous populations, we recruited unrelated individuals of Sicilian origin. PON1 genotype frequencies were comparable to those previously reported in other Caucasian populations, indicating no segregation of PON1 gene variants in our sample. Adults younger than 65 years matched for risk factors and with no signs for CAD were selected as control subjects. Additionally, the number of elder subjects enrolled could be one potential limitation of the present study, however, it should be noted that the sample was clinically well defined.

Finally, it could be hypothesized that the absence of cardiovascular disease in our octogenarians may depended on peculiar diet rich in antioxidants, in fact, Mediterranean

S. Campo et al. / Experimental Gerontology 39 (2004) 1089–1094

polymorphism of paraoxonase and coronary heart disease in type

diabetes. Lancet

,

–

Garin, M.C., James, R.W., Dussoix, P., Blanche, H., Passa, P., Froguel, P., Ruiz, J.,

Paraoxonase polymorphism Met-Leu

is associated with modified serum concentration of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest.

,

–

Serrato, M., Marian, A.J.,

A variant of a human paraoxonase arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest.

,

–

Sanghera, V.K., Saha, N., Aston, C.E., Kamboh, M.I.,

Genetic polymorphisms of paraoxonase and the risk of coronary heart disease. Arterioscl. Thromb. Vasc. Biol.

,

–

Salonen, J.T., Malin, R., Tuomainen, T.P., Nyyssonen, K., Lakka, T.A., Lehtimaki, T.,

Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ

,

–

Herrmann, S.M., Blanc, H., Poirier, O., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J.M., Cambien, F.,

The Gln/Arg polymorphism of human paraoxonase (PON

) is not related to myocardial infarction in the ECTIM study. Atherosclerosis

,

–

Ombres, D., Pannitteri, G., Montali, A., Candeloro, A., Seccareccia, F., Campagna, F., Cantini, R., Campa, P.P., Ricci, G., Arca, M.,

The Gln-Arg

polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler. Thromb. Vasc. Biol.

,

–

Gardemann, A., Philipp, M., Heb, K., Katz, N., Tillmanns, H., Haberbosch, W.,

The paraoxonase Leu- Met

and Gln-Arg

gene polmorphisms are not associated with the risk of coronary heart disease. Atherosclerosis

,

–

Arca, M., Ombres, D., Montali, A., Campagna, F., Manieri, E., Tanzilli, G., Campa, P.P., Ricci, G., Vema, R., Panitteri, G.,

PON

L

M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q

R polymorphism in an Italian population. Eur. J. Clin. Invest.

(

),

–

Leviev, I., James, R.W.,

Promoter polymorphisms of the human paraoxonase PON

gene ad serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol.

,

–

James, R.W., Leviev, I., Ruiz, J., Passa, P., Froguel, P., Blatter Garin, M.C.,

Promoter polymorphism T(-

)C of the paraoxonase PON

gene is a risk factor for coronary heart disease in type

diabetic patients. Diabetes

,

–

James, R.W.,Leviev, I., Ruitz,J., Passa, P.,Froguel,P., Blatte

arin,M.C.,

Promoter polymorphism T(-

)C and relative paraoxonase

deficiency as determinants of risk of coronary artery disease. J. Mol. Med. 79, 457–463.

Med.

,

–

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,

Diabetes Care,

:

–

Hayek, T., Fuhrman, B., Vaya, J., Rosenblant, M., Belinky, P., Coleman, R., Elis, A., Aviram, M.,

Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDK to oxidation and to aggregation. Arterioscler. Thromb. Vasc. Biol.

,

–

Sent`ı, M., Toma`s, M., Vila, J., Marrugat, J., Elousa, R., Sala, J., Masia, R.,

Relationship of age-related myocardial infarction risk and Gln/ Arg

variants of the human paraoxonase

gene: the REGICOR study. Atherosclerosis

(

),

–

Heijmans, B.T., Westendorp, R.G.J., Lagaay, M.A., Knook, D.L., Kluft, C., Slagboom, P.E.,

Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis

,

–

Nikkila, M., Keikkinen, J.,

High density lipoprotein cholesterol and longevity. Age Ageing

,

–

Burke, G.L., Arnold, A.M., Bild, D.E., Cushman, M., Fried, L.P., Newman, A., Nunn, C., Robbins, J.,

Factors associated with healthy aging: the Cardiovascular Health Study. J. Am. Geriatr. Soc.

,

–

Nevin, D.N., Zambon, A., Furlong, C.E., Richter, R.J., Humbert, R., Hokanson, J.E., Brunzell, J.D.,

Paraoxonase genotypes, lipopro- tein lipase activity, and HDL. Arterioscler. Thromb. Vasc. Biol.

(

),

–

Xia, Y., Gueguen, R., Vincent-Viry, M., Siest, G., Visvikis, S.,

Effect of six candidate genes on early aging in a French population. Aging Clin. Exp. Res.

(

),

–

Saha, N., Roy, A.C., Teo, S.H., Tay, J.S.H., Ratnam, S.S.,

Influence of serum paraoxonase polymorphism in serum lipids and apolipopro- teins. Clin. Genet.

,

–

Hegele, R.A., Howard Brunt, J., Connelly, P.W.,